Cargando…
S100A8/A9 in COVID-19 pathogenesis: Impact on clinical outcomes
Coronavirus disease 2019 (COVID-19) has a broad range of clinical manifestations, highlighting the need for specific diagnostic tools to predict disease severity and improve patient prognosis. Recently, calprotectin (S100A8/A9) has been proposed as a potential biomarker for COVID-19, as elevated ser...
Autores principales: | Mellett, Leah, Khader, Shabaana A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8520505/ https://www.ncbi.nlm.nih.gov/pubmed/34728150 http://dx.doi.org/10.1016/j.cytogfr.2021.10.004 |
Ejemplares similares
-
Elevated Level of Circulating but Not Urine S100A8/A9
Identifies Poor COVID-19 Outcomes
por: Mellett, Leah, et al.
Publicado: (2023) -
Induction of alarmin S100A8/A9 mediates activation of aberrant neutrophils in the pathogenesis of COVID-19
por: Guo, Qirui, et al.
Publicado: (2021) -
Advances in Cardiovascular Disease Lipid Research Can Provide Novel Insights Into Mycobacterial Pathogenesis
por: Thirunavukkarasu, Shyamala, et al.
Publicado: (2019) -
Integrated DNA Methylation and Gene Expression Analysis Identified S100A8 and S100A9 in the Pathogenesis of Obesity
por: Chen, Ningyuan, et al.
Publicado: (2021) -
S100A8 and S100A9 in experimental osteoarthritis
por: Zreiqat, Hala, et al.
Publicado: (2010)